Shanghai, China

Huiyan Ni


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huiyan Ni: Innovator in Antitumor Compounds

Introduction

Huiyan Ni is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medical science, particularly in the development of compounds with antitumor activity. His innovative work has the potential to impact cancer treatment positively.

Latest Patents

Huiyan Ni holds a patent for "Water-soluble triterpenephenol compounds having antitumor activity and the preparation thereof." This invention discloses water-soluble triterpenephenol compounds represented by a specific formula, which are designed to exhibit antitumor properties. The patent also details a method for preparing these compounds using quinone methide triterpene compounds as starting materials. The resulting water-soluble compounds can be formulated into various dosage forms, including injections, tablets, capsules, granules, and liniments, with a particular emphasis on their suitability for injection.

Career Highlights

Huiyan Ni is associated with Shanghai Huatuo Medical Science Co., Ltd., where he continues to advance his research and development efforts. His work in the field of antitumor compounds showcases his commitment to improving medical treatments and patient outcomes.

Collaborations

Huiyan Ni collaborates with talented individuals in his field, including Jiafeng Zeng and Junfang Pan. These partnerships enhance the innovative potential of his research and contribute to the development of effective medical solutions.

Conclusion

Huiyan Ni's contributions to the field of antitumor compounds highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…